Merck KGaA's sales on record level according analysts' estimates

Tomorrow the German Merck KGaA KGaA will publish her past quarter's figures. For this year Merck KGaA KGaA's revenue will be around 15,48 billion euros. This is according to the average of the analysts' estimates. The expected revenue would be the highest in her history. This is slightly more than 2016's revenue of 15,02 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2017

The analysts expect for 2017 a net profit of 2,53 billion euros. The majority of the analysts expects for this year a profit per share of 6,21 euros. So the price/earnings-ratio equals 14,95.

For this year the analysts expect a dividend of 1,27 euros per share. The dividend yield is then 1,37 percent. The average dividend yield of the pharmaceutical companies equals a limited 1,33 percent.

Latest estimates around 110 euros

The most recent recommendations for the pharmaceutical company are from Goldman Sachs , Nord Landesbank and Berenberg.

Merck KGaA KGaA's market value equals around 12 billion .

At 13.22 the stock trades 0,19 percent higher at 92,82 euros.

Historical stock prices Merck KGaA KGaA

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.